Repositorio Dspace

Inflammation in Parkinson's disease: role of glucocorticoids

Mostrar el registro sencillo del ítem

dc.contributor.author Herrero, María-Trinidad
dc.contributor.author Estrada, Cristina
dc.contributor.author Maatouk, Layal
dc.contributor.author Vyas, Sheela
dc.date.accessioned 2026-10-21T06:10:19Z
dc.date.available 2026-10-21T06:10:19Z
dc.date.issued 2015
dc.identifier.citation Herrero MT, Estrada C, Maatouk L, Vyas S. Inflammation in Parkinson's disease: role of glucocorticoids. Front Neuroanat. 2015;9:32. doi:10.3389/fnana.2015.00032 PubMed PMID: 25883554; PubMed Central PMCID: PMC4382972
dc.identifier.issn 1662-5129
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/28718
dc.description.abstract Chronic inflammation is a major characteristic feature of Parkinson's disease (PD). Studies in PD patients show evidence of augmented levels of potent pro-inflammatory molecules e.g., TNF-?, iNOS, IL-1? whereas in experimental Parkinsonism it has been consistently demonstrated that dopaminergic neurons are particularly vulnerable to activated glia releasing these toxic factors. Recent genetic studies point to the role of immune system in the etiology of PD, thus in combination with environmental factors, both peripheral and CNS-mediated immune responses could play important roles in onset and progression of PD. Whereas microglia, astrocytes and infiltrating T cells are known to mediate chronic inflammation, the roles of other immune-competent cells are less well understood. Inflammation is a tightly controlled process. One major effector system of regulation is HPA axis. Glucocorticoids (GCs) released from adrenal glands upon stimulation of HPA axis, in response to either cell injury or presence of pathogen, activate their receptor, GR. GR regulates inflammation both through direct transcriptional action on target genes and by indirectly inhibiting transcriptional activities of transcriptional factors such as NF-?B, AP-1 or interferon regulatory factors. In PD patients, the HPA axis is unbalanced and the cortisol levels are significantly increased, implying a deregulation of GR function in immune cells. In experimental Parkinsonism, the activation of microglial GR has a crucial effect in diminishing microglial cell activation and reducing dopaminergic degeneration. Moreover, GCs are also known to regulate human brain vasculature as well as blood brain barrier (BBB) permeability, any dysfunction in their actions may influence infiltration of cytotoxic molecules resulting in increased vulnerability of dopamine neurons in PD. Overall, deregulation of glucocorticoid receptor actions is likely important in dopamine neuron degeneration through establishment of chronic inflammation.
dc.language.iso eng
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.title Inflammation in Parkinson's disease: role of glucocorticoids
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 25883554
dc.relation.publisherversion https://dx.doi.org/10.3389/fnana.2015.00032
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.3389/fnana.2015.00032
dc.journal.title Frontiers in Neuroanatomy


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta